FDA Approved: NEOSTIGMINE METHYLSULFATE — Supplemental Application (Eugia US LLC)

View source ↗

Summary

The FDA approved a supplemental application for Neostigmine Methylsulfate submitted by Eugia US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Neostigmine Methylsulfate (neostigmine methylsulfate)

Snippet

SUPPL AP for NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)